CD9:PA:PA-Amundi MSCI Europe High Dividend UCITS (EUR)

ETF | Others |

Last Closing

USD 197.52

Change

-0.86 (-0.43)%

Market Cap

USD 0.15B

Volume

119.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.90 (-1.93%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-4.30 (-0.73%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-3.15 (-0.75%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

-0.24 (-0.65%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+0.34 (+0.13%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-3.70 (-0.72%)

USD 8.92B
WLD:PA Lyxor UCITS MSCI World D-EUR

-2.37 (-0.64%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

-0.44 (-0.75%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.14 (-0.70%)

USD 6.91B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

-1.11 (-0.67%)

USD 5.17B

ETFs Containing CD9:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.48% 81% B- 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.48% 81% B- 73% C
Trailing 12 Months  
Capital Gain 20.93% 74% C 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.93% 72% C 77% C+
Trailing 5 Years  
Capital Gain 43.78% 61% D- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 43.78% 59% D- 69% C-
Average Annual (5 Year Horizon)  
Capital Gain 12.76% 71% C- 71% C-
Dividend Return 12.76% 70% C- 34% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.50% 72% C 45% F
Risk Adjusted Return 150.14% 99% N/A 50% F
Market Capitalization 0.15B 37% F 51% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.